GeekWire’s startup coverage documents the Pacific Northwest entrepreneurial scene. Sign up for our weekly startup newsletter, and check out the GeekWire funding tracker and venture capital ...
In 2020, for example, Exscalate rapidly identified a lead compound for a new target in a dry eye indication, enabling a Harvard Medical School, Boston, spin-off, Aramis Biosciences, to go from ...
Investor's Business Daily on MSN21d
Avidity Biosciences, Up 441%, Nears Another Record High As Dystrophy Space Heats UpOne of the key players, Avidity Biosciences, is feeling particularly bullish about its chances. Last month, Fulcrum ...
Bright Minds Biosciences announced a non-brokered private placement with expected gross proceeds of $35 million. The company's stock is currently trading with a session volume of about 10.6 million.
Shares of Bright Minds Biosciences on Friday shot higher after pricing a $35 million private placement. The stock was up 70% at $36.86 in pre-market trading. The company said it has priced the ...
With leading researchers from seven institutions, the Quantitative & Computational Biosciences Graduate Program brings together the resources of the Texas Medical Center -- the world's largest complex ...
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...
We're fourth in the UK in terms of the quality of our research (REF 2021). In the REF 2021, 98 per cent of research and impact from the School of Biosciences has been classed as world-leading or ...
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...
The Molecular and Integrative Biosciences Research Programme (MIBS) investigates molecules, viruses, microbes, animal cells, tissues, organ systems and organisms. The programme combines different ...
VANCOUVER, British Columbia, Oct. 18, 2024 (GLOBE NEWSWIRE) -- Bright Minds Biosciences Inc. (CSE: DRUG) (NASDAQ: DRUG) (“Bright Minds” or the “Company”) is pleased to announce a non ...
These are also key issues studied in the Master's Programme in Genetics and Molecular Biosciences. You will acquire knowledge and skills in modern genetics and molecular biosciences. You can ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback